查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1424067

細胞治療市場、份額、規模、趨勢、行業分析報告：按治療類型、按技術、按應用、按地區、按細分市場、預測，2024-2032 年

Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy Type (Allogeneic Therapies and Autologous Therapies); By Technology; By Application; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 119 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，全球細胞治療市場預計將達到248.5億美元。 該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

各種慢性疾病的增加、全球政府支持的增加以及大力投資細胞治療研究和開發的公司的激增正在推動市場的成長。 此外，細胞治療在個人化醫療、再生醫學、免疫治療等方面的不斷擴大的應用也增加了細胞治療在醫療領域的存在。

例如，2024 年 1 月，Pluri 宣布成立一個名為 "PluriCDMO" 的新部門。 新部門將提供類似合約開發和製造設施的細胞治療藥物製造服務。

此外，對細胞療法的需求正在迅速增加，僅 2022 年就有約 1,500 項涉及細胞療法的臨床試驗在 ClinicalTrials.gov 上註冊。 為了滿足這種不斷增長的需求，公司正在以前所未有的規模生產細胞，同時保持安全、品質和功效。 因此，一次性生物反應器和 3D 生物列印等細胞生產的創新解決方案正在快速推出。

將 3D 生物列印和自動化等先進技術整合到細胞療法中正在獲得巨大的關注。 公司越來越多地尋求將這些技術融入細胞療法中，因為這些技術的主要目的是提高整體可擴展性、降低營運成本並提供及時且一致的結果。 例如，2023 年 5 月，Cellular Origins 宣布推出 Constellation，這是一個全自動且可設定的機器人平台。 它專門設計用於自動化先進療法的製造，無需進行大量的製程重新開發。

該市場的驅動因素是CAR-T 細胞療法的日益普及，以及持續不斷的研究工作，重點是增強和改善這些療法的安全性、有效性以及對更廣泛患者群體的使用，正在進一步推動其增長。 例如，2023年12月，Max Healthcare與Immunoact合作在德裡一家醫院推出了CAR-T細胞療法。

細胞治療市場報告亮點

由於遺傳疾病治療的應用不斷增加，自體細胞療法領域將佔據最大份額

由於體細胞技術在免疫治療中的應用越來越多，因此預計該技術將佔據很大份額

由於全球疾病的增加和世界的老化，肌肉骨骼領域將以最快的速度增長。

由於大型製藥公司的存在和細胞療法製造流程的進步，北美在全球市場佔據主導地位

主要市場參與者包括 Merck KGaA、Precision Biosciences、Becton、Dickinson, and Company、CRISPR Therapeutics 和 Thermo Fisher Scientific。

目錄

第1章簡介

第 2 章執行摘要

第3章研究方法

第4章全球細胞治療市場洞察

  • 細胞治療市場 - 技術概覽
  • 細胞治療市場動態
    • 推動者和機會
      • 對有效或強效治療的需求不斷增長，以及對個人化醫療的接受度不斷提高，推動了市場成長
      • 策略夥伴關係和協作可能會推動市場成長
    • 抑制因素和挑戰
      • 高昂的開發成本和複雜的製造流程限制了市場成長
  • PESTEL 分析
  • 細胞治療市場的技術趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第5章全球細胞治療市場（依應用）

  • 主要發現
  • 簡介
  • 肌肉骨骼系統
  • 心血管
  • 胃腸道
  • 神經系統
  • 腫瘤學
  • 皮膚科
  • 傷口
  • 眼科
  • 其他

第 6 章全球細胞治療市場（依治療類型）

  • 主要發現
  • 簡介
  • 同質療法
  • 自我治療

第 7 章全球細胞治療市場：依技術分類

  • 主要發現
  • 簡介
  • 體細胞技術
  • 細胞永生化技術
  • 病毒載體技術
  • 基因組編輯技術
  • 細胞可塑性技術

第 8 章全球細胞治療市場（按地區）

  • 主要發現
  • 簡介
    • 2019-2032 年細胞治療市場評估（按地區）
  • 細胞治療市場 - 北美
    • 北美：細胞治療市場，依應用劃分，2019-2032 年
    • 北美：細胞治療市場（依技術），2019-2032 年
    • 北美：細胞治療市場，依治療類型，2019-2032 年
    • 細胞治療市場-美國
    • 細胞治療市場 - 加拿大
  • 細胞治療市場 - 歐洲
    • 歐洲：細胞治療市場，依應用劃分，2019-2032 年
    • 歐洲：細胞治療市場（依技術），2019-2032 年
    • 歐洲：細胞治療市場，依治療類型，2019-2032 年
    • 細胞治療市場 - 英國
    • 細胞治療市場—法國
    • 細胞治療市場 - 德國
    • 細胞治療市場—義大利
    • 細胞治療市場 - 西班牙
    • 細胞治療市場 - 荷蘭
    • 細胞治療市場—俄羅斯
  • 細胞治療市場 - 亞太地區
    • 亞太地區：細胞治療市場，依應用劃分，2019-2032 年
    • 亞太地區：細胞治療市場（依技術），2019-2032 年
    • 亞太地區：細胞治療市場，依治療類型，2019-2032 年
    • 細胞治療市場 - 中國
    • 細胞治療市場—印度
    • 細胞治療市場 - 馬來西亞
    • 細胞治療市場—日本
    • 細胞治療市場—印度尼西亞
    • 細胞治療市場－韓國
  • 細胞治療市場 - 中東和非洲
    • 中東和非洲：細胞治療市場（按應用），2019-2032 年
    • 中東和非洲：細胞治療市場（按技術），2019-2032 年
    • 中東和非洲：細胞治療市場（按治療類型），2019-2032 年
    • 細胞治療市場－沙烏地阿拉伯
    • 細胞治療市場 - 阿拉伯聯合大公國
    • 細胞治療市場—以色列
    • 細胞治療市場 - 南非
  • 細胞治療市場 - 拉丁美洲
    • 拉丁美洲：細胞治療市場，按應用劃分，2019-2032 年
    • 拉丁美洲：細胞治療市場（依技術），2019-2032 年
    • 拉丁美洲：細胞治療市場，依治療類型，2019-2032 年
    • 細胞治療市場 - 墨西哥
    • 細胞治療市場 - 巴西
    • 細胞治療市場—阿根廷

第9章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第10章公司簡介

  • Becton, Dickinson, and Company（US）
  • Bluebird Bio（US）
  • CRISPR Therapeutics（Switzerland）
  • Fate Therapeutics（US）
  • Lonza Group（Switzerland）
  • Merck KGaA（Germany）
  • Novartis AG（Switzerland）
  • Precision BioSciences（US）
  • Regeneron Pharmaceuticals（US）
  • Sartorius AG（Germany）
  • Takeda Pharmaceutical Company（Japan）
  • Thermo Fisher Scientific Inc.（US）
Product Code: PM4331

The global cell therapy market size is expected to reach USD 24.85 billion by 2032, according to a new study by Polaris Market Research. The report "Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy Team (Allogeneic Therapies and Autologous Therapies); By Technology; By Application; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increasing prevalence of various chronic conditions, rising government assistance worldwide, and surge in the number of companies investing heavily in research & development of cell therapies, are driving the market's growth. Additionally, growing applications of cell therapies in personalized medicine, regenerative medicine, and immunotherapy making them more prominent in the medical field.

For instance, in January 2024, Pluri, announced the launch of its new business division named "PluriCDMO". The new business division will offer cell therapy manufacturing services like a contract development and manufacturing organization.

Furthermore, need for the cell therapies is growing drastically and in 2022 only, around 1,500 clinical trials involving cell therapies were registered with the ClinicalTrials.gov. In order to meet this rising demand, companies producing cells at unprecedented scale while maintaining the safety, quality, and efficacy. Thus, the incorporation of innovative solutions in cell production such as single-use bioreactors and 3D bioprinting are emerging at rapid pace.

The integration of advanced technologies like 3D bioprinting and automation into cell therapies is gaining huge traction. As these technologies mainly aimed at improving the overall scalability, reduce operational costs, and ensure timely & consistent delivery of results, companies are increasingly looking to integrate these technologies into their cell therapies. For instance, in May 2023, Cellular Origins, announced the launch of Constellation, a fully automated and configurable robotic platform. It is specially designed to automate the manufacturing of advanced therapies without major process redevelopment.

Growing adoption of CAR-T cell therapies and ongoing research activities focused on enhancing or improving the safety, efficacy, and applications of these therapies for broader patient population, further escalating the market's growth. For instance, in December 2023, Max Healthcare, introduced CAR-T cell therapy in collaboration with the ImmunoACT at its hospital in Delhi.

Cell Therapy Market Report Highlights

Autologous therapies segment accounted for largest share, on account of its increasing adoption for the treatment of genetic disorders

Somatic cell technology segment expected to hold significant share, due to rising usage of this technology in immunotherapies

Musculoskeletal segment will grow at fastest pace, that is attributed to rise in incidences of these conditions worldwide and global aging population

North America dominated the global market, owing to presence of large pharma companies and advancements in cell therapies manufacturing processes

The key market players include Merck KGaA, Precision Biosciences, Becton, Dickinson, and Company, CRISPR Therapeutics, and Thermo Fisher Scientific

Polaris Market Research has segmented the cell therapy market report based on therapy type, technology, application, and region:

Cell Therapy, Therapy Type Outlook (Revenue - USD Billion, 2023 - 2032)

  • Allogeneic Therapies
  • Autologous Therapies

Cell Therapy, Technology Outlook (Revenue - USD Billion, 2023 - 2032)

  • Somatic Cell Technology
  • Cell Immortalization Technology
  • Viral Vector Technology
  • Genome Editing Technology
  • Cell Plasticity Technology

Cell Therapy, Application Outlook (Revenue - USD Billion, 2023 - 2032)

  • Musculoskeletal
  • Cardiovascular
  • Gastrointestinal
  • Neurological
  • Oncology
  • Dermatology
  • Wound and Injuries
  • Ocular
  • Others

Cell Therapy, Regional Outlook (Revenue - USD Billion, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cell Therapy Market Insights

  • 4.1. Cell Therapy Market - Technology Snapshot
  • 4.2. Cell Therapy Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing need for effective or potent treatments and rising acceptance of personalized medicine to drive market's growth
      • 4.2.1.2. Strategic Partnerships & collaboration are likely to boost market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High development cost and complex manufacturing process to restrain the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cell Therapy Market Technology Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Cell Therapy Market, by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • 5.3. Musculoskeletal
    • 5.3.1. Global Cell Therapy Market, by Musculoskeletal, by Region, 2019-2032 (USD Billion)
  • 5.4. Cardiovascular
    • 5.4.1. Global Cell Therapy Market, by Cardiovascular, by Region, 2019-2032 (USD Billion)
  • 5.5. Gastrointestinal
    • 5.5.1. Global Cell Therapy Market, by Gastrointestinal, by Region, 2019-2032 (USD Billion)
  • 5.6. Neurological
    • 5.6.1. Global Cell Therapy Market, by Neurological, by Region, 2019-2032 (USD Billion)
  • 5.7. Oncology
    • 5.7.1. Global Cell Therapy Market, by Oncology, by Region, 2019-2032 (USD Billion)
  • 5.8. Dermatology
    • 5.8.1. Global Cell Therapy Market, by Dermatology, by Region, 2019-2032 (USD Billion)
  • 5.6. Wound and Injuries
    • 5.6.1. Global Cell Therapy Market, by Wound and Injuries, by Region, 2019-2032 (USD Billion)
  • 5.7. Ocular
    • 5.7.1. Global Cell Therapy Market, by Ocular, by Region, 2019-2032 (USD Billion)
  • 5.8. Others
    • 5.8.1. Global Cell Therapy Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Cell Therapy Market, by Therapy Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • 6.3. Allogeneic Therapies
    • 6.3.1. Global Cell Therapy Market, by Allogeneic Therapies, by Region, 2019-2032 (USD Billion)
  • 6.4. Autologous Therapies
    • 6.4.1. Global Cell Therapy Market, by Autologous Therapies, by Region, 2019-2032 (USD Billion)

7. Global Cell Therapy Market, by Technology

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • 7.3. Somatic Cell Technology
    • 7.3.1. Global Cell Therapy Market, by Somatic Cell Technology, By Region, 2019-2032 (USD Billion)
  • 7.4. Cell Immortalization Technology
    • 7.4.1. Global Cell Therapy Market, by Cell Immortalization Technology, By Region, 2019-2032 (USD Billion)
  • 7.5. Viral Vector Technology
    • 7.5.1. Global Cell Therapy Market, by Viral Vector Technology, By Region, 2019-2032 (USD Billion)
  • 7.6. Genome Editing Technology
    • 7.6.1. Global Cell Therapy Market, by Genome Editing Technology, By Region, 2019-2032 (USD Billion)
  • 7.7. Cell Plasticity Technology
    • 7.7.1. Global Cell Therapy Market, by Cell Plasticity Technology, By Region, 2019-2032 (USD Billion)

8. Global Cell Therapy Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Cell Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Cell Therapy Market - North America
    • 8.3.1. North America: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
    • 8.3.2. North America: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
    • 8.3.3. North America: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.3.4. Cell Therapy Market - U.S.
      • 8.3.4.1. U.S.: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.3.5. Cell Therapy Market - Canada
      • 8.3.5.1. Canada: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.4. Cell Therapy Market - Europe
    • 8.4.1. Europe: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.4.4. Cell Therapy Market - UK
      • 8.4.4.1. UK: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.4.5. Cell Therapy Market - France
      • 8.4.5.1. France: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.4.6. Cell Therapy Market - Germany
      • 8.4.6.1. Germany: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.4.7. Cell Therapy Market - Italy
      • 8.4.7.1. Italy: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.4.8. Cell Therapy Market - Spain
      • 8.4.8.1. Spain: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.4.9. Cell Therapy Market - Netherlands
      • 8.4.9.1. Netherlands: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.4.10. Cell Therapy Market - Russia
      • 8.4.10.1. Russia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.5. Cell Therapy Market - Asia Pacific
    • 8.5.1. Asia Pacific: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.5.4. Cell Therapy Market - China
      • 8.5.4.1. China: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.5.5. Cell Therapy Market - India
      • 8.5.5.1. India: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.5.6. Cell Therapy Market - Malaysia
      • 8.5.6.1. Malaysia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.5.7. Cell Therapy Market - Japan
      • 8.5.7.1. Japan: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.5.8. Cell Therapy Market - Indonesia
      • 8.5.8.1. Indonesia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.5.9. Cell Therapy Market - South Korea
      • 8.5.9.1. South Korea: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.6. Cell Therapy Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.6.4. Cell Therapy Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.6.5. Cell Therapy Market - UAE
      • 8.6.5.1. UAE: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.6.6. Cell Therapy Market - Israel
      • 8.6.6.1. Israel: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.6.7. Cell Therapy Market - South Africa
      • 8.6.7.1. South Africa: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • 8.7. Cell Therapy Market - Latin America
    • 8.7.1. Latin America: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.7.4. Cell Therapy Market - Mexico
      • 8.7.4.1. Mexico: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.7.5. Cell Therapy Market - Brazil
      • 8.7.5.1. Brazil: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
    • 8.7.6. Cell Therapy Market - Argentina
      • 8.7.6.1. Argentina: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Becton, Dickinson, and Company (US)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bluebird Bio (US)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. CRISPR Therapeutics (Switzerland)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Fate Therapeutics (US)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Lonza Group (Switzerland)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Merck KGaA (Germany)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Novartis AG (Switzerland)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Precision BioSciences (US)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Regeneron Pharmaceuticals (US)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Sartorius AG (Germany)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Takeda Pharmaceutical Company (Japan)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Thermo Fisher Scientific Inc. (US)
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development

List of Tables

  • Table 1 Global Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 2 Global Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 3 Global Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 4 Cell Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 6 North America: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 7 North America: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 8 U.S.: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 9 U.S.: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 11 Canada: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 12 Canada: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 13 Canada: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 14 Europe: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 15 Europe: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 16 Europe: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 17 UK: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 18 UK: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 19 UK: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 20 France: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 21 France: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 22 France: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 23 Germany: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 24 Germany: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 25 Germany: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 26 Italy: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 27 Italy: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 28 Italy: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 29 Spain: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 30 Spain: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 31 Spain: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 35 Russia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 36 Russia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 37 Russia: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 41 China: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 42 China: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 43 China: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 44 India: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 45 India: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 46 India: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 50 Japan: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 51 Japan: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 52 Japan: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 56 South Korea: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 57 South Korea: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 58 South Korea: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 65 UAE: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 66 UAE: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 67 UAE: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 68 Israel: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 69 Israel: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 70 Israel: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 71 South Africa: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 72 South Africa: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 73 South Africa: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 74 Latin America: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 75 Latin America: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 76 Latin America: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 77 Mexico: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 78 Mexico: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 79 Mexico: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 80 Brazil: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 81 Brazil: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)
  • Table 83 Argentina: Cell Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 84 Argentina: Cell Therapy Market, by Therapy Type, 2019-2032 (USD Billion)
  • Table 85 Argentina: Cell Therapy Market, by Technology, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Cell Therapy Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Therapy Type
  • Figure 7. Global Cell Therapy Market, by Therapy Type, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global Cell Therapy Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Technology
  • Figure 11. Global Cell Therapy Market, by Technology, 2022 & 2032 (USD Billion)
  • Figure 12. Cell Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Cell Therapy Market